“Third party providers of hospital-based physicians, including those with whom we contract, have experienced significant disruption in the form of regulatory changes, including those stemming from enactment of the No Surprises Act, challenging labor market con…”10-Q · May 6, 2026 ↗
Ardent Health, Inc.
ARDT
Market read
Ardent Health, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
- ARDT's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ARDT's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- ARDT's market-adjusted activity becomes unusual and at least one connected name confirms.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +6.0% year over year.
- Operating cash flow covered net income at 3.46x in the latest annual period.
- Macroeconomic conditions has repeated favorable evidence across 4 filings.
- Net margin changed -1.4 percentage points in the latest annual period.
- Diluted shares increased 6.6% in the latest annual period.
- Credit and interest rates has repeated adverse evidence across 3 filings.
- P/E is 48% below the available filing-peer median; determine whether growth and quality justify the difference.
- EV/sales is 81% below the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 10, 2026
10.89Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“During the year ended December 31, 2024, the Company released its liability for unrecognized tax benefits, as well as the accrued interest expense related to the unrecognized tax benefits, due to the expiration of its statute of limitations.”10-K · Mar 16, 2026 ↗
“We also expect these reforms to ACA marketplace exchange-based plans to adversely impact results in 2026, partially offset by our ongoing resiliency and cost reduction initiatives.”10-Q · May 6, 2026 ↗
“The decrease in supplies as a percentage of total revenue was primarily attributable to an increase in revenue from Medicaid supplemental payment programs compared to the same prior year period and ongoing supply chain initiatives.”10-Q · May 6, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 0.2× · EV/sales 0.3×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 14:05 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for ARDT. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for ARDT. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind ARDT
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
VTRVentas, Inc.distributorMay 6, 2026 ▾
“Rents and leases, related party — Rents and leases, related party, consisted of lease expense related to the Ventas Master Lease and other lease agreements with Ventas for certain medical office buildings.”
VTRVentas, Inc.partnerMar 16, 2026 ▾
“Ventas Master Lease Effective August 4, 2015, we sold the real property for ten of our hospitals to Ventas, which is a related party as, prior to our IPO, it was a common unit holder of Ardent Health Partners, LLC and owned shares of common stock of AHP Healt…”
Depended on by
VTRVentas, Inc.investeeApr 28, 2026 ▾
“Our investments in unconsolidated entities also includes investments in operating entities, such as Ardent Health, Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ARDT is currently a Early Follower in the organic co-movement group Auto & Communication Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for ARDT; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.